Direct growth hormone injection is subject to negative feedback, where high blood levels cause the pituitary and brain to shut down endogenous growth hormone production; this drove the development of secretagogue peptides that stimulate the body's own growth hormone release by mimicking hypothalamic signals rather than directly supplying growth hormone.

causalpending

Speaker

Andrew Huberman

Evidence Quote

people have developed peptide therapeutics that stimulate the release of growth hormone and thereby the release of IGF-1, but not by directly stimulating the growth hormone pathway.

Source

Benefits & Risks of Peptide Therapeutics for Physical & Mental HealthAndrew Huberman
Created: 6/18/2026, 1:57:48 PM

My Notes

Loading notes...